Manufacture of pharmaceutical preparations
CURIDA AS
Revenue 2024
NOK 279.8m
Operating profit
NOK 3.1m
Equity
NOK 26.1m
Incorporated
2015
Employees
133
Share capital
NOK 15.0m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 279.8m | |
| Total operating costs | 276.6m | |
| Operating profit (EBIT) | 3.1m | |
| Net financial items | −16.9m | |
| Profit for the year | −13.4m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 217.2m | |
| of which current assets | 138.1m | |
| Equity | 26.1m | |
| Total liabilities | 191.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.